Latest by Michelle Andrews

Hep C and Drug Abuse Often Go Hand in Hand, but Screening for Infection Lags

The number of people who inject drugs has soared, yet many drug patients are not checked for the virus that can damage the liver.

By Michelle Andrews for Henry J. Kaiser Family Foundation

Hepatitis C Drug's Lower Cost Paves Way for Medicaid, Prisons to Expand Treatment

The recent approval of a less expensive drug that generally cures hepatitis C in just eight weeks may make it easier for more insurers and correctional facilities to expand treatment.

By Michelle Andrews for Henry J. Kaiser Family Foundation

Kids With Hepatitis C Get New Drugs and Coverage May Prove Easier Than for Adults

With the approval this month of two drugs to treat hepatitis C in children, these often overlooked victims of the opioid epidemic have a better chance at a cure.

By Michelle Andrews for Henry J. Kaiser Family Foundation

Medicaid Denies Nearly Half of Requests for Hepatitis C Drugs: Study

People with hepatitis C who sought prescriptions for highly effective but pricey new drugs were significantly more likely to get turned down if they had Medicaid coverage than if they were insured by Medicare or private commercial policies, a recent ...

By Michelle Andrews for Kaiser Health News

Study Finds Marketplace Silver Plans Offer Poor Access to HIV Drugs

In most states, consumers with HIV who buy silver-level plans on the insurance marketplaces find limited coverage of common drug regimens they may need and high out-of-pocket costs, according to a new analysis.

By Michelle Andrews for Kaiser Health News